GlaxoSmithKline PLC (NYSE:GSK)

40.00
Delayed Data
As of Apr 20
 +0.12 / +0.30%
Today’s Change
34.52
Today|||52-Week Range
44.54
+12.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues37.9B36.5B37.5B38.9B
 
 
 
 
 
Cost of Goods Sold9.4B11.1B10.3B10.5B
 
 
 
 
 
Depreciation And Amortization2.4B2.5B2.4B2.5B
 
 
 
 
 
 
Operating ExpensesGross Income26.0B22.9B24.8B25.9B
 
 
 
 
 
General Expenses16.9B16.2B15.7B15.6B
 
 
 
 
 
Research And Development5.2B5.2B4.7B5.0B
 
 
 
 
 
Total Operating Expenses28.8B29.8B28.4B28.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income9.1B6.7B9.1B10.3B
 
 
 
 
 
Extraordinary Credit19.8M47.3M191.1M--
 
 
 
 
Extraordinary Charge-4.5B-7.2B-7.1B-5.5B
 
 
 
 
 
Interest Expense On Debt1.1B1.0B923.2M898.9M
 
 
 
 
 
Equity In Earnings49.4M21.4M6.7M16.7M
 
 
 
 
 
Other Expenses1.2B17.4B1.3B600.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.8B16.0B2.6B4.5B
 
 
 
 
 
Income Taxes-225.6M-3.3B-1.2B-1.7B
 
 
 
 
 
Minority Interest-123.5M-76.3M-201.9M-820.3M
 
 
 
 
 
Net Income4.5B12.8B1.2B2.0B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.4B2.4B2.4B2.4B
 
 
 
 
 
Shares To Calculate EPS Diluted2.4B2.4B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$1.89$5.32$0.51$0.81
 
 
 
 
 
EPS Diluted$1.86$5.26$0.50$0.80